CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
133 hedge funds and large institutions have $475M invested in CTI BioPharma Corp. (DE) Common Stock in 2023 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 55 increasing their positions, 33 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
41% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 29
Holders
133
Holding in Top 10
3
Calls
$4.31M
Puts
$2.85M
Top Buyers
| 1 | +$37.6M | |
| 2 | +$25M | |
| 3 | +$10.9M | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$6.73M |
| 5 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$3.89M |
Top Sellers
| 1 | -$16.4M | |
| 2 | -$15M | |
| 3 | -$13M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$10.6M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$7.61M |